Cytena launches new microbioreactor

By The Science Advisory Board staff writers

July 20, 2021 -- Cellink company Cytena Bioprocess Solutions has unveiled its new S.Nest microbioreactor.

Suitable for cell-line development, S.Nest is a high-throughput reactor that features real-time monitoring, according to the firm. It includes reciprocating mixing technology, incubation chambers with individual environmental controls, and a camera module for real-time monitoring of pH and dissolved oxygen, Cytena said.

In addition, S.Nest comes with analytics software and is compatible with 96-well or 24-well culture plates. The microbioreactor's four chambers enable simultaneous culturing of as many as 384 wells, Cytena said.

S.Nest utilizes suspension culturing nourished by a continuous supply of oxygen, according to the company.

Leveraging optofluidics to make therapeutic antibody discovery easier
The need for speed and accuracy in the development of therapeutic antibodies has prompted Berkeley Lights to upgrade its optofluidic tools to help customers...
Berkeley Lights offers new assays to aid cell line development
Berkeley Lights has launched Opto Assure, a series of assays that provides yield and product quality data during the early stages of cell line development.
Bioelectronica nabs financing to advance antibody discovery platform
Proxima Ventures and Co-win Ventures have invested in Bioelectronica to advance the company's digital biochemistry innovations, including novel assay...

Copyright © 2021

CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter